Is Juluca a Controlled Substance? No

No. Juluca (dolutegravir and rilpivirine) is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and dolutegravir and rilpivirine is not on the DEA controlled substances list.

Run it in Rivvi

Which 2027 plans near you dropped or restricted Juluca?

Tier changes and new prior auth, step therapy or quantity limits, plan by plan.

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Schedule check

Schedule sources for Juluca
Source	What it lists
FDA NDC directory	1 prescription listings from 1 labelers, none with a DEA schedule
DEA controlled substances list	dolutegravir and rilpivirine is not on the list

Juluca NDC listings

NDC listings for Juluca
NDC	Product	Form	Strength	Labeler	DEA schedule
49702-242	Juluca	tablet, film coated	50 mg/1; 25 mg/1	ViiV Healthcare Company	None

Questions

Is Juluca a controlled substance?

No. Juluca (dolutegravir and rilpivirine) is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and dolutegravir and rilpivirine is not on the DEA controlled substances list.

Is Juluca a narcotic?

No. Juluca (dolutegravir and rilpivirine) is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic. Its FDA established pharmacologic class is Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor and Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor.

Does this page cover state schedules?

No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.